Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors-Reference-Cited by-同舟云学术

Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors

Published:2022-01 Issue: Volume:227 Page:113916
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Hwang Soo-Yeon,Shrestha Aarajana,Park Seojeong,Bist Ganesh,Kunwar Surendra,Kadayat Tara Man^ORCID,Jang Haejin,Seo Minjung,Sheen Naeun,Kim Seojeong,Jeon Kyung-Hwa,Lee Eung-Seok,Kwon Youngjoo^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference88 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA;Bray;Cancer J. Clin.,2018

2. Physiological functions of programmed DNA breaks in signal-induced transcription;Puc;Nat. Rev. Mol. Cell Biol.,2017

3. Recent developments in topoisomerase-targeted cancer chemotherapy;Hevener;Acta Pharm. Sin. B.,2018

4. DNA topoisomerases: harnessing and constraining energy to govern chromosome topology;Schoeffler;Q. Rev. Biophys.,2008

5. Targeting DNA topoisomerase II in cancer chemotherapy;Nitiss;Nat. Rev. Mol. Cell Biol.,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1);Chemistry & Biodiversity;2024-04-12

2. Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma;European Journal of Medicinal Chemistry;2024-02

3. Di-indenopyridines as topoisomerase II-selective anticancer agents: Design, synthesis, and structure–activity relationships;Bioorganic & Medicinal Chemistry;2023-08

4. New benzothienopyran and benzothienopyranopyrimidine derivatives as topoisomerase I inhibitors: Design, synthesis, anticancer screening, apoptosis induction and molecular modeling studies;Bioorganic Chemistry;2023-08

5. Synthesis and evaluation of 7-(3-aminopropyloxy)-substituted flavone analogue as a topoisomerase IIα catalytic inhibitor and its sensitizing effect to enzalutamide in castration-resistant prostate cancer cells;European Journal of Medicinal Chemistry;2023-01